Kizzmekia Corbett

Q: What types of brand work does Kizzmekia Corbett do?

Brand Partnerships, Campaign collaborations, endorsements, social media activations, commercials (TV/digital), voiceovers, and media appearances.

Q: What influences pricing for brand deals?

Usage rights, exclusivity, deliverables, campaign length, timelines, and production scope.

Q: What information do you need for a proposal?

Please share your brand, campaign objectives, deliverables, usage period/territory, deadlines, and budget range.

Q: Can Kizzmekia Corbett create custom content for our campaign?

Yes — Kizzmekia Corbett can deliver bespoke content (videos, posts, appearances, endorsements) aligned to your creative brief.

Q: Does Kizzmekia Corbett do voiceovers or on-camera work?

Yes — subject to concept approval and scheduling.

Q: Can Kizzmekia Corbett also participate in other types of events or campaigns?

Yes — many of our talent are versatile and can engage in speaking engagement, or media/brand activations, depending on their individual skills and availability.

Kizzmekia Corbett, a distinguished viral immunologist, is recognized for her pivotal role in the development of the Moderna COVID-19 vaccine, demonstrating her expertise in microbiology and immunology.

Book Kizzmekia Corbett

102.8K

Audience Reach

Kizzmekia Corbett

Past Works

Moderna, Inc.

The vaccine concept incorporated in mRNA-1273 was designed by Dr. Corbett's NIH team from viral sequence and rapidly deployed to industry partner, Moderna, Inc.

BRAND PARTNERSHIPS

Born January 26, 1986

MILESTONE

circa 2020

Led the National Institutes of Health (NIH) team that designed the vaccine concept incorporated in mRNA-1273 for COVID-19

MILESTONE

circa 2020

Collaboration with Moderna, Inc. for rapid vaccine deployment

MILESTONE

Appointed Melvin J. and Geraldine L. Glimcher assistant professor of immunology and infectious diseases at Harvard's T.H. Chan School of Public Health

MILESTONE

Appointed Shutzer Assistant Professor at the Harvard Radcliffe Institute

MILESTONE

About

Kizzmekia S. Corbett-Helaire was born on January 26, 1986. An American viral immunologist, she has become a prominent figure in the field of vaccine development. Her early career focused on understanding the complexities of viral immunology, laying the groundwork for her later significant contributions. Dr. Corbett-Helaire’s academic journey and research interests consistently centered on developing countermeasures for emerging infectious diseases.

Dr. Corbett-Helaire gained widespread recognition for her critical contributions to the development of the mRNA-1273 vaccine, a leading vaccine for COVID-19. As a scientist at the National Institutes of Health (NIH), she led the team that designed the vaccine concept from viral sequence. This work involved close collaboration with the industry partner, Moderna, Inc., enabling the rapid deployment of the vaccine. Her expertise in viral immunology was instrumental in this accelerated development process, showcasing her ability to translate complex scientific research into practical applications for public health.

Currently, Dr. Kizzmekia Corbett-Helaire serves as the Melvin J. and Geraldine L. Glimcher assistant professor of immunology and infectious diseases at Harvard’s T.H. Chan School of Public Health and is also the Shutzer Assistant Professor at the Harvard Radcliffe Institute. Her career progression highlights a continuous commitment to advancing scientific knowledge and applying it to address global health crises. She continues to utilize her viral immunology expertise to propel novel vaccine development for pandemic preparedness, influencing future responses to infectious disease threats and inspiring future generations in the scientific community.